T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.58B |
| 2 |
T-Mobile US
TMUS
|
+$1.53B |
| 3 |
Morgan Stanley
MS
|
+$1.15B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.15B |
| 5 |
Apple
AAPL
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$2.94B |
| 2 |
Amazon
AMZN
|
+$2.82B |
| 3 |
GE Aerospace
GE
|
+$1.93B |
| 4 |
Goldman Sachs
GS
|
+$1.88B |
| 5 |
ServiceNow
NOW
|
+$1.28B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.25% |
| 2 | Healthcare | 17.75% |
| 3 | Financials | 11.32% |
| 4 | Consumer Discretionary | 11.17% |
| 5 | Communication Services | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Veru
VERU
$43.3M
| $62K | ﹤0.01% |
5,267
+1,181
| +29% | +$47.8K |
|
2752
Cardiff Oncology
CRDF
$96.5M
| $61K | ﹤0.01% |
36,500
| – | – |
|
2753
Destination XL Group
DXLG
$27.7M
| $61K | ﹤0.01% |
10,960
+825
| +8% | +$5.23K |
|
2754
PEDEVCO
PED
$174M
| $61K | ﹤0.01% |
2,875
-1,115
| -28% | -$22.2K |
|
2755
XBiotech
XBIT
$66.2M
| $61K | ﹤0.01% |
17,600
| – | – |
|
|
NAGE
2756
Niagen Bioscience
NAGE
$241M
| $61K | ﹤0.01% |
39,300
| – | – |
|
|
SYRS
2757
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $61K | ﹤0.01% |
22,550
+10,400
| +86% | +$40.3K |
|
2758
Akebia Therapeutics
AKBA
$248M
| $60K | ﹤0.01% |
105,500
-61,400
| -37% | -$46.9K |
|
2759
Aqua Metals
AQMS
$9.34M
| $60K | ﹤0.01% |
299
-260
| -47% | -$60.8K |
|
2760
Clover Health Investments
CLOV
$2.38B
| $60K | ﹤0.01% |
69,854
-153,349
| -69% | -$168K |
|
2761
SelectQuote
SLQT
$70.6M
| $58K | ﹤0.01% |
26,400
-87,441
| -77% | -$141K |
|
|
DNMR
2762
DELISTED
Danimer Scientific, Inc.
DNMR
| $58K | ﹤0.01% |
416
+9
| +2% | +$823 |
|
2763
SmartRent
SMRT
$228M
| $57K | ﹤0.01% |
22,242
-62,801
| -74% | -$168K |
|
2764
Shattuck Labs
STTK
$609M
| $57K | ﹤0.01% |
19,300
| – | – |
|
2765
Savara
SVRA
$1.03B
| $57K | ﹤0.01% |
28,960
| – | – |
|
|
FFAI
2766
Faraday Future Intelligent Electric
FFAI
$9.86M
| – | – |
0
| – | – |
|
2767
Caribou Biosciences
CRBU
$133M
| $56K | ﹤0.01% |
+10,546
| New | +$65.7K |
|
2768
Invivyd
IVVD
$275M
| $56K | ﹤0.01% |
46,639
-466,564
| -91% | -$852K |
|
2769
Lipocine
LPCN
$17.3M
| $56K | ﹤0.01% |
10,271
-591
| -5% | -$4.57K |
|
2770
Phunware
PHUN
$40.3M
| $56K | ﹤0.01% |
1,572
+634
| +68% | +$29.4K |
|
2771
Neuronetics
STIM
$209M
| $56K | ﹤0.01% |
19,100
| – | – |
|
|
EXPR
2772
DELISTED
Express, Inc.
EXPR
| $56K | ﹤0.01% |
3,533
| – | – |
|
|
VBIV
2773
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $55K | ﹤0.01% |
5,997
| – | – |
|
2774
Ampco-Pittsburgh
AP
$178M
| $53K | ﹤0.01% |
21,600
| – | – |
|
2775
PLAYSTUDIOS Inc
MYPS
$57.2M
| $53K | ﹤0.01% |
14,165
| – | – |
|
Similar funds
T. Rowe Price Associates's Q1 2023 Portfolio in Review
As of Q1 2023, T. Rowe Price Associates held 3,020 positions worth $668B, up 7.5% from $622B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2023 filing shows 65 new, 1,711 increased, 924 reduced and 98 closed positions. Its largest new stake was Suncor Energy: 6,437,236 shares worth $200M. The largest sale was Alphabet (Google) Class C, an estimated $2.94B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2023 buy was Suncor Energy: 6,437,236 shares worth $200M.
- T. Rowe Price Associates added most to Tesla in Q1 2023, an estimated $1.58B increase.
- T. Rowe Price Associates's biggest Q1 2023 reduction was Alphabet (Google) Class C, cutting an estimated $2.94B.
- T. Rowe Price Associates fully exited Signature Bank in Q1 2023, selling an estimated $360M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $668B portfolio in Q1 2023.
- T. Rowe Price Associates opened 65 new positions and closed 98 in Q1 2023.
- T. Rowe Price Associates's portfolio value rose 7.5% quarter-over-quarter to $668B.
Based on T. Rowe Price Associates's 13F filing for Q1 2023, filed 15 May 2023.